From Policy to Practice: A Vital Conversation on the Future of Diagnostic Equity in Oncology – EAPM
European Alliance for Personalised Medicine (EAPM) shared a post on LinkedIn:
“Save the Date!
Join us on September 6th, 2025, in Vienna for a vital conversation on the future of diagnostic equity in oncology. The European Alliance for Personalised Medicine (EAPM) will host a high-level side event during the European Society of Pathology (ESP) Congress:
‘From Policy to Practice: Advancing Universal HER2 Testing Standards for Diagnostic Equity and Uptake of Digital Pathology’
- 13:00 – 15:30 CET
- Austria Center Vienna (ACV)
With HER2-targeted therapies expanding rapidly across multiple tumor types, outdated diagnostic protocols are putting patients at risk. This session will bring together leading voices in pathology, policy, and digital innovation to advance a roadmap for universal, reliable, and patient-centered HER2 testing.
Key themes include:
- Policy foundations for equitable access
- Integration of digital pathology into routine workflows
- Global standards and patient rights in diagnostics
- Practical implementation strategies from across Europe
Let’s shift from identifying the gaps to delivering real-world solutions.
View the Agenda.
Register here to attend the event.”
More posts featuring EAPM.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023